Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis.

scientific article published on 7 December 2015

Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10875-015-0215-8
P698PubMed publication ID26644312
P5875ResearchGate publication ID283894665

P50authorShibabrata MukherjeeQ86867893
P2093author name stringSusmita Ghosh
Nilay K Das
Mitali Chatterjee
Joyashree N Barbhuiya
Debanjan Mukhopadhyay
P2860cites workDirect association of adenosine deaminase with a T cell activation antigen, CD26Q24322080
Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasisQ24633365
IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovaniQ24658015
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signallingQ28189055
Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasisQ28268702
Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivoQ31838727
CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.Q33892260
Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patientsQ33927377
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO.Q33947051
Analysis of localized immune responses reveals presence of Th17 and Treg cells in cutaneous leishmaniasis due to Leishmania tropicaQ35051071
IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasisQ35188445
CD8 T cell exhaustion in human visceral leishmaniasisQ37416246
Dipeptidyl peptidase in autoimmune pathophysiology.Q37853155
Leishmaniasis: complexity at the host-pathogen interface.Q37900121
Post kala-azar dermal leishmaniasis: an unresolved mysteryQ38175646
A male preponderance in patients with Indian post kala-azar dermal leishmaniasis is associated with increased circulating levels of testosteroneQ39279491
A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral LeishmaniasisQ39412297
Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activationQ44606441
Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasisQ46483508
Impaired expression of CD26 compromises T-cell recruitment in human visceral leishmaniasis.Q50946650
Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytesQ68318310
A novel pathway of human T cell activation via a 103 kD T cell activation antigenQ70322731
CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune responseQ77378978
Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individualsQ77886591
Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasisQ81180513
CD26 expression on CD4+T cells in patients with cutaneous leishmaniasisQ81224632
Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5Q81795672
High concentration of adenosine in human visceral leishmaniasis despite increased ADA and decreased CD73Q84507171
Miltefosine effectively modulates the cytokine milieu in Indian post kala-azar dermal leishmaniasisQ84967561
P433issue1
P921main subjectIndiaQ668
visceral leishmaniasisQ2046113
P304page(s)85-94
P577publication date2015-12-07
P1433published inJournal of Clinical ImmunologyQ6294961
P1476titleDecreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis
P478volume36

Reverse relations

cites work (P2860)
Q33724960A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.
Q61444559Impaired activation of lesional CD8 T-cells is associated with enhanced expression of Programmed Death-1 in Indian Post Kala-azar Dermal Leishmaniasis
Q26749758Possibilities and challenges for developing a successful vaccine for leishmaniasis

Search more.